Sort
30,917 grants matching “tumor microenvironment”
A Phase IIa Study of rHuIL-12 as an Immunotherapy and Radiomitigator for CTCL Patients Receiving Radiotherapy
$417,175Lena A. Basile · Neumedicines, Inc. · R44 · FY2016 · CA
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease
$417,066Matthew J. Flick · Cincinnati Childrens Hosp Med Ctr · R01 · FY2018 · CA
Function of IL35+ B cells in pancreatic cancer
$417,022Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2025 · CA
Autophagy Heterogeneity and Tumor Metastasis
$417,005Hong-Gang Wang · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2021 · CA
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
$417,003Qing Yi · Methodist Hospital Research Institute · R01 · FY2023 · CA
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
$417,003Qing Yi · Methodist Hospital Research Institute · R01 · FY2022 · CA
Modulation of Anti-Tumor Immunity by Inhibitory Receptors
$416,987Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2019 · AI
Visual Analytics for Exploration and Hypothesis Generation Using Highly MultiplexedSpatial Data of Tissues and Tumors
$416,968Hanspeter Pfister · Harvard Medical School · U01 · FY2025 · CA
Metabolic interactions between tumor cells and the immunce system in GBM A potential Achilles heel of GBM for novel therapeutics
$416,964Loic Pierre Deleyrolle · University Of Florida · R01 · FY2023 · NS
Targeting ovarian cancer spheroid formation and metabolic adaptation by APJ inhibition
$416,950Sukyung Woo · State University Of New York At Buffalo · R01 · FY2022 · CA
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
$416,939Ethel Cesarman · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
$416,939Ethel Cesarman · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
$416,939Ethel Cesarman · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
$416,939Ethel Cesarman · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
$416,939Ethel Cesarman · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Causes and Consequences of Acid pH in Tumors
$416,929University Of Arizona · R01 · FY2005 · CA
Improving CAR-T cell therapy in metastatic breast cancers by reprogramming obesity-aggravated tumor microenvironment via physical activity
$416,818Dai Fukumura · Massachusetts General Hospital · R21 · FY2025 · CA
TlBr Detectors for High Resolution PET Imaging
$416,815Gregory Scott Mitchell · University Of California At Davis · R01 · FY2016 · CA
Effects of Complement on the Tumor Microenvironment in Lung Cancer
$416,813Raphael A. Nemenoff · University Of Colorado Denver · R01 · FY2019 · CA
Deciphering MDSC function for GBM targeting
$416,765Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · NS
Fatty Acid Synthase /Molecular Target /Breast Cancer The
$416,745Northshore Univ Healthsystem Res Inst · R01 · FY2005 · CA
Promoting Endogenous Cell Recruitment for Rotator Cuff Muscle Repair
$416,741Johnna S Temenoff · Georgia Institute Of Technology · R01 · FY2018 · AR
Genetic Mechanisms Controlling Kidney Cancer Immune Escape
$416,677Haydn Kissick · Emory University · R01 · FY2025 · CA
Oncolytic virus therapeutic responses occur from changes in the glioblastoma immune microenvironment
$416,647E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2020 · NS
Preclinical Development of iRGD for Pancreatic Cancer
$416,564Deborah Slee · Aspyrian Therapeutics, Inc. · R43 · FY2011 · CA